Provided by Tiger Trade Technology Pte. Ltd.

Black TITAN Corp

1.64
-0.0799-4.65%
Volume:28.88K
Turnover:48.08K
Market Cap:14.90M
PE:-0.55
High:1.71
Open:1.69
Low:1.64
Close:1.72
52wk High:39.00
52wk Low:1.51
Shares:9.09M
Float Shares:1.70M
Volume Ratio:2.76
T/O Rate:1.70%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.9620
EPS(LYR):0.3057
ROE:--
ROA:--
PB:14.84
PE(LYR):5.37

Loading ...

Company Profile

Company Name:
Black TITAN Corp
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
37
Office Location:
The Bousteador,Level 8, Unit 802,10 Jalan PJU 7/6,Mutiara Damansara,Petaling Jaya,Selangor,Malaysia
Zip Code:
47800
Phone:
- -
Fax:
- -
Introduction:
Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases in the United States and internationally. It develops products based on ProNeura, a proprietary long-term drug delivery platform. It also develops TP-2021 in combination with ProNeura technology for the treatment of chronic pruritus, a severe and debilitating condition defined as itching of the skin lasting longer than six weeks; and Nalmefene implant program for the prevention of opioid relapse following detoxification of patients suffering opioid use disorder. The company was founded in 1991 and is based in South San Francisco, California.

Directors

Name
Position
Chay Weei Jye
Co-Chief Executive Officer and Director
Avraham Ben Tzvi
Independent Director
Brynner Chiam
Chief Financial Officer and Director
Firdauz Edmin Bin Mokhtar
Independent Director
Francisco Osvaldo Flores Garcia
Independent Director
Gabriel Loh
Independent Director

Shareholders

Name
Position
Chay Weei Jye
Co-Chief Executive Officer and Director
Shang Ju Lin
Co-Chief Executive Officer
Brynner Chiam
Chief Financial Officer and Director